Yuval Kluger

22.5k citations

155 papers · 12.4k indexed · 7 hit papers · h-index 56

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
Molecular Biology top 0.5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Bioinformatics and Genomic Networks
- Genomics and Chromatin Dynamics
- Gene expression and cancer classification
- Cancer-related gene regulation
- Single-cell and spatial transcriptomics

Papers in

Biophysics 8
Molecular Biology 92
- Gene expression and cancer classification 21
- Single-cell and spatial transcriptomics 20
- Genomics and Chromatin Dynamics 17
- Epigenetics and DNA Methylation 11
- Bioinformatics and Genomic Networks 11

Co-authors: Emil Mottola Mark Gerstein Fabio Parisi Brian David Dynlacht Uri Shaham Fred Cooper Tingting Jiang Harriet M. Kluger
Journals: Nucleic Acids Research (8 papers)Clinical Cancer Research (7 papers)Proceedings of the National Academy of Sciences (7 papers)Molecular Cell (6 papers)Nature Communications (5 papers)
Partner nations: United States Israel Canada

In The Last Decade

Yuval Kluger

153 papers receiving 12.2k citations

Hit Papers

7 papers align trajectories log scale

IL-10 constrains sphingolipid metabolism to limit inflammation 2024 · 113 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature
2019 Nature Methods
2018 BMC Medical Research Methodology
2017 Nature
2012 Molecular Cell
2007 Molecular Cell
2003 Science

Peers

Countries citing papers authored by Yuval Kluger

Since Specialization

Citations

This map shows the geographic impact of Yuval Kluger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuval Kluger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuval Kluger more than expected).

Fields of papers citing papers by Yuval Kluger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuval Kluger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuval Kluger. The network helps show where Yuval Kluger may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuval Kluger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuval Kluger Line = papers co-authored together Yuval Kluger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nerve-associated macrophages control adipose homeostasis across lifespan and restrain age-related inflammation Nature Aging ·Elsie Gonzalez-Hurtado, Claire Leveau, Keyi Li, Manish Mishra, Rihao Qu, Emily L. Goldberg, Sviatoslav Sidorov, Payal Damani‐Yokota, Stephen T. Yeung, Camille Khairallah, David González, Taverlyn M. Shepard, Christina D. Camell, Maxim N. Artyomov, Yuval Kluger, Kamal M. Khanna, Vishwa Deep Dixit	2025	2
2	IL-6 trans-signaling in a humanized mouse model of scleroderma Proceedings of the National Academy of Sciences ·Ian D. Odell, Kriti Agrawal, Esen Sefik, A.V. Odell, Elizabeth Caves, Nancy C. Kirkiles-Smith, Valerie Horsley, Monique Hinchcliff, Jordan S. Pober, Yuval Kluger, Richard A. Flavell	2023	9
3	Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation JCI Insight ·Fang Lyu, Chase Burzynski, Yuan Fang, Aya Tal, Alice Y. Chen, Jacqueline Kisa, Kriti Agrawal, Yuval Kluger, Hugh S. Taylor, Reshef Tal	2023	6
4	Zero-preserving imputation of single-cell RNA-seq data Nature Communications ·George C. Linderman, Jun Zhao, Manolis Roulis, Piotr Bielecki, Richard A. Flavell, Boaz Nadler, Yuval Kluger	2022	125
5	m ⁶ A mRNA modification maintains colonic epithelial cell homeostasis via NF-κB–mediated antiapoptotic pathway Science Advances ·Ting Zhang, Chenbo Ding, Huifang Chen, Jun Zhao, Zhejun Chen, Baiwen Chen, Kaiqiong Mao, Yajuan Hao, Manolis Roulis, Hao Xu, Yuval Kluger, Qiang Zou, Youqiong Ye, Meixiao Zhan, Richard A. Flavell, Huabing Li	2022	58
6	Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations Blood Advances ·Jingjing Ren, Rihao Qu, Nur-Taz Rahman, Julia M. Lewis, Amber Loren Ong King, Xiaofeng Liao, Fatima N. Mirza, Kacie R. Carlson, Yaqing Huang, Scott Gigante, Benjamin Evans, Barani Kumar Rajendran, Suzanne Xu, Guilin Wang, Francine M. Foss, William Damsky, Yuval Kluger, Smita Krishnaswamy, Michael Girardi	2022	11
7	Detection of differentially abundant cell subpopulations in scRNA-seq data Proceedings of the National Academy of Sciences ·Jun Zhao, Ariel Jaffe, Henry Li, Ofir Lindenbaum, Esen Sefik, Ruaidhrí Jackson, Xiuyuan Cheng, Richard A. Flavell, Yuval Kluger	2021	68
8	Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence Contemporary Clinical Trials Communications ·Alysse Schultheis, Mark Sanchez, Savannah F. Pedersen, Tassos C. Kyriakides, Ya‐Chi Ho, Yuval Kluger, Sandra A. Springer	2021	2
9	Alignment free identification of clones in B cell receptor repertoires Nucleic Acids Research ·Ofir Lindenbaum, Nima Nouri, Yuval Kluger, Steven H. Kleinstein	2020	14
10	Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic Infection Control and Hospital Epidemiology ·Dan M. Kluger, Yariv Aizenbud, Ariel Jaffe, Fabio Parisi, Lilach Aizenbud, Eyal Minsky-Fenick, Jonathan Kluger, Shelli Farhadian, Harriet M. Kluger, Yuval Kluger	2020	29
11	Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry Clinical Cancer Research ·Daniel Carvajal‐Hausdorf, Jonathan Patsenker, Kelly Stanton, Franz Villarroel‐Espíndola, Amanda Esch, Ruth R. Montgomery, Amanda Psyrri, Konstantine T. Kalogeras, Vassiliki Kotoula, George Foutzilas, Kurt A. Schalper, Yuval Kluger, David L. Rimm	2019	40
12	Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data Nature Methods ·George C. Linderman, Manas Rachh, Jeremy G. Hoskins, Stefan Steinerberger, Yuval Kluger Hit paper breakdown →	2019	323
13	Genomic Heterogeneity and the Small Renal Mass Clinical Cancer Research ·Daiki Ueno, Zuoquan Xie, Marta Boeke, Jamil Syed, Kevin A. Nguyen, Patrick D. McGillivray, Adebowale Adeniran, Peter A. Humphrey, Garrett M. Dancik, Yuval Kluger, Zongzhi Liu, Harriet M. Kluger, Brian Shuch	2018	13
14	Gating mass cytometry data by deep learning Bioinformatics ·Huamin Li, Uri Shaham, Kelly Stanton, Yi Yao, Ruth R. Montgomery, Yuval Kluger	2017	58
15	PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors Clinical Cancer Research ·Harriet M. Kluger, Christopher R. Zito, Gabriela Turcu, Marina K. Baine, Hongyi Zhang, Adebowale Adeniran, Mario Sznol, David L. Rimm, Yuval Kluger, Lieping Chen, Justine V. Cohen, Lucia B. Jilaveanu	2017	111
16	PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis Clinical Cancer Research ·Lucia B. Jilaveanu, Fabio Parisi, Meaghan L. Barr, Christopher R. Zito, William Cruz‐Muñoz, Robert S. Kerbel, David L. Rimm, Marcus Bosenberg, Ruth Halaban, Yuval Kluger, Harriet M. Kluger	2014	57
17	Plasma Markers for Identifying Patients with Metastatic Melanoma Clinical Cancer Research ·Harriet M. Kluger, Kathleen Hoyt, Antonella Bacchiocchi, Tina Mayer, Jonathan Kirsch, Yuval Kluger, Mario Sznol, Stephan Ariyan, Annette M. Molinaro, Ruth Halaban	2011	77
18	Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma Clinical Cancer Research ·Saadia A. Aziz, Michael A. Davies, Elah Pick, Christopher R. Zito, Lucia B. Jilaveanu, Robert L. Camp, David L. Rimm, Yuval Kluger, Harriet M. Kluger	2009	50
19	Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer Clinical Cancer Research ·Yasmine Nadler, Robert L. Camp, Candice Schwartz, David L. Rimm, Harriet M. Kluger, Yuval Kluger	2008	110
20	A Bayesian Networks Approach for Predicting Protein-Protein Interactions from Genomic Data Science ·Ronald Jansen, Haiyuan Yu, Dov Greenbaum, Yuval Kluger, Nevan J. Krogan, Sambath Chung, Andrew Emili, M Snyder, Jack Greenblatt, Mark Gerstein Hit paper breakdown →	2003	916

About Yuval Kluger

Yuval Kluger is a scholar working on Biophysics, Molecular Biology, Immunology, Cancer Research and Nuclear and High Energy Physics, having authored 155 papers that have together received 12.4k indexed citations. Recurring topics across this work include Gene expression and cancer classification (21 papers), Single-cell and spatial transcriptomics (20 papers), Genomics and Chromatin Dynamics (17 papers), Immune Cell Function and Interaction (13 papers), Epigenetics and DNA Methylation (11 papers), Bioinformatics and Genomic Networks (11 papers), T-cell and B-cell Immunology (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (7.2k citations), Immunology (1.5k citations), Oncology (1.8k citations) and Cell Biology (1.0k citations). Yuval Kluger has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Emil Mottola, Mark Gerstein, Fabio Parisi, Brian David Dynlacht, Uri Shaham, Fred Cooper, Tingting Jiang, Harriet M. Kluger, Alexandre Blais and Jonathan Bates. Their work appears in journals such as Nucleic Acids Research, Clinical Cancer Research, Proceedings of the National Academy of Sciences, Molecular Cell and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact